Free guide · A printable companion
A Woman's Guide to Peptide Therapy.
A printable companion to Anthivera — the questions to bring to your first consult, a one-page peptide chart, and the 2026 regulatory timeline at a glance. 8 pages, designed to print and write on.
May 2026 edition · 8 pages
We'll send the PDF and add you to Anthivera Insider (one careful email a week). Unsubscribe anytime.
The PDF is the companion, not the archive
The website is the deep, current source — long-form articles, the live provider comparison, and a weekly dispatch as the landscape evolves. The PDF is what you print, write on, and hand to a clinician. Tactile tools, not duplicated content.
What's inside
01
A printable first-consult checklist
Twelve questions worth asking before you start. Designed to print, with space for the provider's answers — bring it to your appointment.
02
A one-page peptide-comparison chart
Every peptide we cover side by side — category, FDA status, women's relevance, strength of evidence — on a single sheet you can scan in 60 seconds.
03
The 2026 regulatory timeline, as a graphic
Category 2 (2023) → removed for ~12 peptides (April 2026) → PCAC review (July 2026), in one clear graphic. Always verify current status with a provider.
04
The red-flag spotter
How to recognize gray-market vendors, unsafe providers, and the marketing tactics worth running from. A short list, written for women, easy to share.
The guide is editorial. It compares and informs — it doesn't recommend treatment for any condition. See our medical disclaimer. Regulatory information is current as of May 2026 and may change; always verify with a licensed clinician.